The objective of the Biostatistics Resource is to be strategically involved in the design, implementation, and analysis of clinical and scientific data generated by CCSG program members. This includes the articulation of study objectives, characterization of hypotheses, the derivation of appropriate designs and models to cost-effectively achieve a study's objectives, the assurance that modern and appropriate statistical and mathematical data analytic methods are used, monitoring interim and final analyses, and assisting in the writing of abstracts and manuscripts. The expertise provided by the staff ensures that the yield of useful information from the scientific studies conducted at Roswell Park Cancer Institute is maximized while the costs are minimized. Concepts and tools from the disciplines of statistics, mathematics, engineering science, and computer science are used to accomplish these goals. Most projects require the use of standard and commercially available tools. Occasionally, a particular laboratory or clinical problem requires an innovative solution for which the Resource develops the novel methodology. The Biostatistics Resource fosters intra-, inter- and extra-programmatic creativity and productivity, and provides objective and critical feedback to RPCI researchers as they seek answers to complex problems, when the numbers of experimental subjects must be kept small, when ethical concerns are critical, and when the goals of a research project demand the integrated participation of multiple scientific groups. With the appointment of James Kepner, PhD, a distinguished biostatistician, as Director in August 2002, the Resource is being restructured with input from the Resource's Advisory Committee and the CCSG Steering Committee, of which Dr. Kepner is a member. Some of the ways in which the Resource's expanded and enhanced capabilities are being made known to program leaders are through referrals, by the Scientific Review Committee's insistence that protocols and grant applications have input from a biostatistician, formal seminars given by Resource staff, and Dr. Kepner's presentations at program meetings.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-31
Application #
7417846
Study Section
Project Start
2007-05-01
Project End
2008-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
31
Fiscal Year
2007
Total Cost
$256,286
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Fenstermaker, Robert A; Figel, Sheila A; Qiu, Jingxin et al. (2018) Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo. Clin Cancer Res 24:2642-2652
Bhat, Tariq A; Kalathil, Suresh Gopi; Bogner, Paul N et al. (2018) Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections. J Immunol 200:2927-2940
Miller, James A; Harris, Kassem; Roche, Charles et al. (2018) Sarcopenia is a predictor of outcomes after lobectomy. J Thorac Dis 10:432-440
Qin, Bo; Llanos, Adana A M; Lin, Yong et al. (2018) Validity of self-reported weight, height, and body mass index among African American breast cancer survivors. J Cancer Surviv 12:460-468
Qiao, Guanxi; Chen, Minhui; Bucsek, Mark J et al. (2018) Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response. Front Immunol 9:164
Merzianu, Mihai; Groman, Adrienne; Hutson, Alan et al. (2018) Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study. Am J Clin Pathol 150:393-405
Liu, Chunhong; Yu, Tao; Xing, Zhuo et al. (2018) Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors. Oncotarget 9:4773-4786
Muramatsu, Masashi; Akakura, Shin; Gao, Lingqiu et al. (2018) SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk. Oncotarget 9:33515-33527
Kumar, Sandeep; Inigo, Joseph R; Kumar, Rahul et al. (2018) Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Cancer Lett 413:82-93
Shenoy, Gautam N; Loyall, Jenni; Maguire, Orla et al. (2018) Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses. Cancer Immunol Res 6:236-247

Showing the most recent 10 out of 1555 publications